LivaNova PLC (LIVN) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Livanova Plc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:06.079 Ladies and gentlemen, and welcome to the Levenover PLC first quarter 2025 earnings 00:00:06.079 -- 00:00:10.365 conference call. My name is Emily and I'll be coordinating your call today. 00:00:10.365 -- 00:00:14.010 As a reminder, this conference call is being recorded. 00:00:14.010 -- 00:00:17.875 I would now like to introduce your host for today's conference, Ms. 00:00:17.875 -- 00:00:22.201 Brianna Gotland, Levenover's Vice President of Investor Relations. 00:00:22.201 -- 00:00:24.661 Please go ahead. 00:00:27.503 -- 00:00:32.107 Thank you and welcome to our conference call and webcast discussing LevaNova's financial 00:00:32.107 -- 00:00:35.330 results for the first quarter of 2025. 00:00:35.330 -- 00:00:40.595 Joining me on today's call are Vladimir Makatsaria, our Chief Executive Officer and member 00:00:40.595 -- 00:00:46.060 of the Board of Directors, Alex Schwartzberg, our Chief Financial Officer, Amit 00:00:46.060 -- 00:00:50.805 Tozel, our Chief Innovation Officer, Stephanie Bolton, President of Global Epilepsy, 00:00:50.805 -- 00:00:54.841 and Zach Glazer, Director of Investor Relations. 00:00:54.841 -- 00:00:58.885 Before we begin, I would like to remind you that the discussions during this call will 00:00:58.885 -- 00:01:02.026 include forward-looking statements. 00:01:02.208 -- 00:01:06.613 Factors that could cause actual results to differ materially are discussed in the company's 00:01:06.613 -- 00:01:11.838 most recent filings and documents furnished to the SEC, including today's press release 00:01:11.838 -- 00:01:17.864 that is available on our website. We do not undertake to update any forward-looking statements. 00:01:17.864 -- 00:01:22.088 Also, the discussions will include certain non-GAAP financial measures...